Ironwood Pharmaceuticals | Należności Handlowe





Należności Handlowe Zmiana Data
Acadia Pharmaceuticals USD 139.44M 19.75M 2025-09
Agios Pharmaceuticals USD 5.03M 43K 2025-09
Akebia Therapeutics USD 61.54M 27.17M 2025-03
Almirall EUR 193.8M 20.72M 2025-06
Alnylam Pharmaceuticals USD 964.77M 397.66M 2025-09
Amarin USD 127.31M 8.18M 2025-09
Ardelyx USD 76.61M 14.06M 2025-09
Astellas Pharma JPY 810.23B 75.43B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Charles River Laboratories USD 1.48B 715.2M 2025-09
Coherus Biosciences USD 62.44M 59.9M 2025-03
Esperion Therapeutics USD 60.36M 5.75M 2024-06
Exact Sciences USD 306.05M 47.28M 2025-09
Halozyme Therapeutics USD 346.04M 29.7M 2025-09
Incyte USD 1.02B 128.52M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Lexicon Pharmaceuticals USD 2.62M 1.09M 2024-06
MacroGenics USD 69.23M 56.7M 2025-09
Moderna USD 1.05B 589M 2025-09
Myriad Genetics USD 118M 19M 2025-09
Pacira USD 115.27M 901K 2025-09
PTC Therapeutics USD 203.07M 6.94M 2025-09
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
Takeda JPY 757.92B 55.68B 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12


Ironwood Pharmaceuticals Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.